CG
Chandrashekar Gulabrao Ingle
About Chandrashekar Gulabrao Ingle
Chandrashekar Gulabrao Ingle has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Prowings Health Solution Private Limited and Winstonepoint Pharmaceuticals Private Limited. Formerly with 1 company, such as Saialexin Pharmaceutical Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Prowings Health Solution Private Limited
U51909PN2018PTC178282
|
Director | 04 Dec 2018 | 2018 | Active |
Winstonepoint Pharmaceuticals Private Limited
U74999PN2017PTC171444
|
Director | 13 Jul 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Saialexin Pharmaceutical Private Limited
U74999PN2016PTC164959
|
Director | 13 Jun 2016 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chandrashekar Gulabrao Ingle
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chandrashekar Gulabrao Ingle
Chandrashekar Gulabrao Ingle has 10 years in corporate governance. Holds Director role. Currently with 2 companies, including Prowings Health Solution Private Limited and Winstonepoint Pharmaceuticals Private Limited. Formerly with 1 company, such as Saialexin Pharmaceutical Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Chandrashekar Gulabrao Ingle is associated with 2 companies as Director.
Chandrashekar Gulabrao Ingle has expertise in Healthcare, General Business.
Chandrashekar Gulabrao Ingle has 10 years in corporate governance.